Kenneth M. Cohen, President and CEO at Somaxon Pharmaceuticals, Inc. (SOMX), sold 4,391 shares at $13.15 ($57K) on 2006-10-06, disclosed to the SEC on 2006-10-10.
Scheduled sale ($57k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.57 | 1,219 | $15K | 26.9% |
| 2 | $13.15 | 3,172 | $42K | 73.1% |
| Total | $12.99 avg | 4,391 | $57K | 100% |
| Filing → |
| MBVX | BUY | 2014-12-18 | $5K | — | Filing → |
| MBVX | BUY | 2014-12-17 | $10K | — | Filing → |
| SOMX | SELL | 2007-04-27 | $360K | — | Filing → |